Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease
暂无分享,去创建一个
K. Morgan | J. Roca | W. MacNee | N. Kalsheker | V. Keatings | A. Millar | S. Donnelly | S. Monti | M. Miniati | P. Hiemstra | R. Rabinovich | S. Chappell | J. Stolk | L. Daly | Tamar Guetta Baranes | C. O'connor | T. Baranes | W. Macnee | Vera M. Keatings
[1] K. Morgan,et al. Haplotypes of the alpha‐1 antitrypsin gene in healthy controls and Z deficiency patients , 2004, Human mutation.
[2] E. Silverman,et al. Chronic obstructive pulmonary disease in α1-antitrypsin PI MZ heterozygotes: a meta-analysis , 2004, Thorax.
[3] Kun Zhang,et al. HaploBlockFinder: Haplotype Block Analyses , 2003, Bioinform..
[4] Peter H. Westfall,et al. Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.
[5] Giorgio Gabella,et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.
[6] E. Silverman. Genetics of chronic obstructive pulmonary disease. , 2008, Novartis Foundation symposium.
[7] A. Sandford,et al. Genetic risk factors for chronic obstructive pulmonary disease. , 2002, Clinics in chest medicine.
[8] P. Sham,et al. Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.
[9] J. Pritchard,et al. Use of unlinked genetic markers to detect population stratification in association studies. , 1999, American journal of human genetics.
[10] A. Gulsvik. Mortality in and prevalence of chronic obstructive pulmonary disease in different parts of Europe. , 1999, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[11] J. Spinelli,et al. Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. , 1999, American journal of respiratory cell and molecular biology.
[12] B Rosner,et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.
[13] A. Boutten,et al. Oncostatin M Is a Potent Stimulator of α1-Antitrypsin Secretion in Lung Epithelial Cells: Modulation by Transforming Growth Factor- β and Interferon- γ , 1998 .
[14] A. Sandford,et al. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. , 1998, Disease markers.
[15] K. Morgan,et al. Mutation in an alpha1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors. , 1997, Biochimica et biophysica acta.
[16] J. Spinelli,et al. Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease. , 1997, Journal of medical genetics.
[17] S. Al‐Awadi,et al. TaqI polymorphism in the 3' flanking region of the PI gene among Kuwaiti Arabs and Russians. , 1997, Disease markers.
[18] M. D. de Santi,et al. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[19] D. Postma,et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. , 1992, Thorax.
[20] W. Poller,et al. Mis-sense mutation of alpha 1-antichymotrypsin gene associated with chronic lung disease. , 1992, Lancet.
[21] W. Poller,et al. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. , 1990, European journal of clinical investigation.
[22] R. Crystal,et al. Molecular basis of alpha-1-antitrypsin deficiency. , 1988, The American journal of medicine.
[23] G. Snider,et al. Animal models of emphysema. , 1986, The American review of respiratory disease.
[24] M Terrin,et al. Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.
[25] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.
[26] J. Lieberman,et al. Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease. , 1973, Journal of Occupational Medicine.